Searched for
SPECIALTY PHARMACEUTICALS
ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil PatelZydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- Protein boom sparks deals, partnerships across F&B spaceConsumer demand for protein in everyday staples is driving new product launches and supply deals. Food and beverage makers and cafe chains ...
- These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos have upside potential of up to 25%, according to analystsTalk of tariffs, especially steep ones, makes the market nervous. Which is exactly why the next few trading sessions are critical, and why ...
- Advent International joins India’s hospital gold rush with Rs 3,150 crore Yatharth betAdvent International will invest Rs 3,150 crore in Yatharth Hospitals for a significant stake. This marks one of the largest private equity...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Prasol Chemicals shares list at 10% discount to IPO price on BSE, NSEThe Rs 550 crore public issue was priced at Rs 676 per share. The offering comprised a fresh issue of 11.83 lakh shares worth Rs 80 crore a...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- Brookfield looks to buy PGP Glass for up to $1.5 bn from BlackstoneBrookfield is negotiating to acquire PGP Glass from Blackstone for $1.3 billion. This deal marks a significant transaction between two majo...
- EV-related stocks: Own the chain, not the guess; 13 stocks with upside potential of up to 28% and downside risk of -14%, according to analystsIn the stock market, when a big theme or sectoral trend takes off, most investors focus on the face of it. A brand with which they can rela...
- India-China trade: The numbers behind the relationship as Xi visits DelhiChinese President Xi Jinping's visit highlights India-China trade's stark imbalance. India's imports from China vastly exceed its exports, ...
- Prasol Chemicals IPO Day 3: Check GMP, subscription status and other detailsPrasol Chemicals IPO enters its final bidding day with muted demand and zero GMP, pointing to expectations of a flat listing. The Rs 500 cr...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos may rally over 21%, according to analystsWith the US market shedding weight overnight, the probability is high that Thursday will see another day of choppy trading. The best way to...
- Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocksAt the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies ...
- Can Prasol Chemicals IPO deliver long-term growth for high-risk investors?Prasol Chemicals plans an IPO to raise funds for debt repayment and expansion. The company's revenue and profits have shown significant gro...
- Prasol Chemicals fixes price band for Rs 500-cr IPO; issue to open on Sep 8Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...
Load More
